Editas Medicine (EDIT) Preferred Dividend Payments (2015 - 2016)
Editas Medicine (EDIT) posted quarterly Preferred Dividend Payments of $47000.0 for Q1 2016, down 50.53% year-over-year from $95000.0 in Q2 2015, and down 52.53% quarter-over-quarter from $99000.0 in Q4 2015.
Powered by 
Analysis
Editas Medicine (EDIT) Preferred Dividend Payments (2015 - 2016) Analysis & Trends
Editas Medicine (EDIT) has reported Preferred Dividend Payments for 2 consecutive years, with $47000.0 the latest figure, recorded in Q1 2016.
- In Q1 2016, Preferred Dividend Payments fell 50.53% year-over-year to $47000.0; the TTM figure through Dec 2016 stood at $47000.0 (down 88.07% YoY), while the FY2016 annual figure was $47000.0, down 88.07% from the prior year.
- Preferred Dividend Payments slipped to $47000.0 in Q1 2016 per EDIT's latest filing, from $99000.0 in the prior quarter.
- Across five years, Preferred Dividend Payments topped out at $104000.0 in Q3 2015 and bottomed at $47000.0 in Q1 2016.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Editas Medicine | 287.84 Mn | 141.19 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2016 | 47,000.00 |
| Dec 31, 2015 | 99,000.00 |
| Sep 30, 2015 | 104,000.00 |
| Jun 30, 2015 | 96,000.00 |
| Mar 31, 2015 | 95,000.00 |